Evidence map›Paper›PMID 38989987›Full record

ArticleFuture medicinal chemistry2024

Synthesis, anti-diabetic profiling and molecular docking studies of 2-(2-arylidenehydrazinyl)thiazol-4(5

Hasnain Mehmood, Muhammad Haroon, Tashfeen Akhtar, Simon Woodward, Saadia Haq, Saad M Alshehri

Abstract read
In one paragraph

Article in Future medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hasnain MehmoodDepartment of Chemistry, Mirpur University of Science & Technology (MUST), 10250, Mirpur (AJK), Pakistan.ORCID 0000-0003-0997-3231
Muhammad HaroonDepartment of Chemistry & Biochemistry, Miami University 651, E. High Street, Oxford, 45056, Ohio, USA.ORCID 0000-0002-7386-5107
Tashfeen AkhtarDepartment of Chemistry, Mirpur University of Science & Technology (MUST), 10250, Mirpur (AJK), Pakistan.ORCID 0000-0002-4815-0687
Simon WoodwardGSK, Carbon Neutral Laboratories for Sustainable Chemistry, University Park Nottingham, NG7 2RD, United Kingdom.ORCID 0000-0001-8539-6232
Saadia HaqInstitute of Chemistry, Khwaja Fareed University of Engineering & Information Technology, Rahim Yar Khan, 64200, Pakistan.ORCID 0009-0006-1124-5865
Saad M AlshehriDepartment of Chemistry, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia.ORCID 0000-0002-4990-6183

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

alpha-AmylasesHypoglycemic AgentsMolecular Docking SimulationThiazolesAntioxidantsHumansMolecular StructureStructure-Activity Relationshipalpha-AmylasesAntioxidantsHypoglycemic AgentsThiazolesanti-diabeticcyto-toxicityHRMSmolecular dockingNMRSARthiazol-4(5H)-ones

Identifiers

PMID38989987
PMCPMC11244696

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.